Long-term follow-up of an IgA nephropathy cohort: outcomes and risk factors

Long-term follow-up of an IgA nephropathy cohort: outcomes and risk factors

Aim IgA nephropathy (IgAN), the most common glomerulopathy worldwide and in Uruguay, raised treatment controversies. The study aimed to analyze long-term IgAN outcomes and treatment.Methods A retrospective analysis of a Uruguayan IgAN cohort, enrolled between 1985 and 2009 and followed up until 2020...

Full description

Bibliographic Details
Main Authors: Liliana Gadola, María Jimena Cabrera, Mariela Garau, Ruben Coitiño, María Haydée Aunchayna, Oscar Noboa, María Asunción Alvarez, Sylvia Balardini, Graciela Desiderio, Nelson Dibello, Alejandro Ferreiro, Soledad Giró, Leonella Luzardo, Alfredo Maino, Lucía Orihuela, María Gabriela Ottati, Andrés Urrestarazú
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Renal Failure
Subjects:
IgA nephropathy
risk factors
kidney replacement therapy
outcomes
Online Access:https://www.tandfonline.com/doi/10.1080/0886022X.2022.2152694

Internet

https://www.tandfonline.com/doi/10.1080/0886022X.2022.2152694

Similar Items